Hull University Teaching Hospitals NHS Trust

Specialist MDT: Hull University Teaching Hospitals NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
  • Support Service Facilities:
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling
    • Genetic counselling

Data Quality

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 423 1114
Performance Status recorded 57% 71%
PSA completed 84% 91%
Gleason Score completed 77% 74%
TNM completed 78% 80%

Disease Presentation

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men with disease status determined 1065 39897
Percentage of men diagnosed with metastatic disease 21% 17%

Management

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men diagnosed with low-risk localised disease 119 4684
Percentage of men with low-risk localised disease receiving radical treatment 4% 8%
No. of men diagnosed with locally advanced disease 509 15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment 74% 68%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023) 207
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 10%
No. of men who received radical prostatectomy (September 2020 - August 2021) 140
Adjusted percentage of men experiencing at least one GU complication (%) 2%
No. of men who received radical radiotherapy (September 2020 - August 2021) 244
Adjusted percentage of men experiencing at least one GI complication (%) 14%

Compare provider outcomes